Joaquin Duato’s Post

View profile for Joaquin Duato, graphic
Joaquin Duato Joaquin Duato is an Influencer

Tackling the world’s toughest health challenges as Chairman and Chief Executive Officer of Johnson & Johnson

Who do we innovate for? At Digestive Disease Week (#DDW2024), the answer was clear: patients. While in Washington, I met with healthcare professionals and Johnson & Johnson colleagues who are all laser-focused on researching and delivering advanced Inflammatory Bowel Disease treatments to help nearly 10 million people worldwide. There was a lot of excitement for the latest clinical data that shows long-lasting, clinical remission may be possible. When looking at clinical data, I always remind myself that every data point is a person. That more human point of reference really brings home how meaningful the data on a poster presentation is. Thank you to patients around the world who take part in clinical trials. You are the true heroes of scientific progress. Johnson & Johnson Innovative Medicine #JNJImmunology #InflammatoryBowelDisease

  • No alternative text description for this image
Mamtha Gopal

Johnson & Johnson, Robotics & Digital Solutions

2mo

My son is one in the 10 M with severe Crohn’s and i respect the professionals and our J&J colleagues ❤️

Thank you for sharing these insights from Digestive Disease Week. It's truly inspiring to see the dedication towards advancing treatments for Inflammatory Bowel Disease. The reminder that every data point represents a person is a powerful perspective. Looking forward to more breakthroughs in this critical field. How do you see the clinical landscape evolving in the next few years?

Like
Reply
Jim Swanson

Executive Vice President, Chief Information Officer at Johnson & Johnson

2mo

Very inspiring to see the impact of our work at #DDW2024. Thanks for leading us to keep patients at the center of everything we do. 

Like
Reply
Serdar B.

Regional Lead | Middle East, Africa and TURGAN | Global Security @ Johnson and Johnson

2mo

What a true heroes indeed. We all owe a lot to you!

Like
Reply
Marco Gouvea

Staff Automation and Controls Engineer at Johnson & Johnson

2mo

👏🏻👏🏻👏🏻

Like
Reply
Derek Deihl

FLDP Analyst at Johnson & Johnson

2mo

As a Crohn’s patient about to begin my FLDP with J&J, thank you for your innovation!

See more comments

To view or add a comment, sign in

Explore topics